Erythroleukemia in a renal transplant recipient

Cancer. 1979 May;43(5):1924-6. doi: 10.1002/1097-0142(197905)43:5<1924::aid-cncr2820430551>3.0.co;2-b.

Abstract

A 53-year-old male developed acute erythroleukemia three years after renal transplantation. He had received three years of immunosuppressive therapy with azathioprine. A preleukemia phase associated with chromosome abnormalities was recognized. Azathioprine has been associated with chromosome abnormalities. The chronic stimulation of an abnormal erythroid clone by transplantation may have hastened the development of erythroleukemia.

Publication types

  • Case Reports

MeSH terms

  • Azathioprine / adverse effects
  • Chromosome Aberrations
  • Humans
  • Kidney Transplantation*
  • Leukemia, Erythroblastic, Acute / etiology*
  • Male
  • Middle Aged
  • Preleukemia / genetics

Substances

  • Azathioprine